Srinath Adusumalli is a Cardiology physician affiliated with University of Pennsylvania Health System. OpenAlex indexes 112 publications with 3,328 citations (h-index 23); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3400 Civic Center Blvd
2 East
Philadelphia, PA 191045127
Telephone
215-615-4949Registry record last updated 3 May 2018.
Clinical trials
- Effect of a Virtually Implemented Cardiac Rehabilitation Program
Sponsor: University of Pennsylvania
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Siemens Medical Solutions USA, Inc.Program year20251 payment
- Philips North America LLCProgram year20251 payment
- Boston Scientific CorporationProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2022)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
82.2%Statin32.2%Atorvastatin Calcium81%Rosuvastatin Calcium19%Part D<11 patientsCalcium channel blocker13.1%Amlodipine Besylate100%Part D<11 patients+ 4 more classes in this area
Blood & clotting
17.8%Factor Xa inhibitor9.8%Eliquis100%Part D<11 patientsP2Y12 inhibitor7.9%Clopidogrel100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A Vision for the Future of Quality in Echocardiographic Reporting: The American Society of Echocardiography ImageGuideEcho Registry, Current and Future States
Journal of the American Society of Echocardiography
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Jerome Strauss, MD, PhD
University of Pennsylvania Health System
Arthur Staddon, MD
University of Pennsylvania Health System
Keith Calligaro, MD
University of Pennsylvania Health System
Fiona Simpkins, MD
University of Pennsylvania Health System
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”